1Life Healthcare (NASDAQ:ONEM – Get Rating) was downgraded by stock analysts at William Blair from an “outperform” rating to a “market perform” rating in a research note issued on Thursday, The Fly reports.
Other equities analysts have also issued reports about the stock. Deutsche Bank Aktiengesellschaft lowered shares of 1Life Healthcare from a “buy” rating to a “hold” rating and boosted their price target for the company from $11.00 to $12.00 in a research report on Tuesday, July 12th. Stifel Nicolaus began coverage on shares of 1Life Healthcare in a research report on Thursday, May 26th. They issued a “buy” rating and a $12.00 price target on the stock. Canaccord Genuity Group reduced their price target on shares of 1Life Healthcare from $18.00 to $14.00 and set a “buy” rating on the stock in a research report on Thursday, May 5th. BTIG Research upgraded shares of 1Life Healthcare from a “neutral” rating to a “buy” rating and set a $15.00 price target on the stock in a research report on Thursday, July 7th. Finally, Guggenheim began coverage on shares of 1Life Healthcare in a research report on Tuesday, March 29th. They set a “neutral” rating on the stock. Ten analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $19.73.
1Life Healthcare Stock Performance
NASDAQ ONEM opened at $17.15 on Thursday. The stock has a market cap of $3.33 billion, a P/E ratio of -9.63 and a beta of 1.74. The company’s 50-day simple moving average is $9.10 and its 200 day simple moving average is $9.89. 1Life Healthcare has a twelve month low of $5.94 and a twelve month high of $30.18. The company has a quick ratio of 2.61, a current ratio of 2.64 and a debt-to-equity ratio of 0.19.
Institutional Investors Weigh In On 1Life Healthcare
Large investors have recently bought and sold shares of the company. CWM LLC bought a new stake in 1Life Healthcare in the fourth quarter valued at approximately $30,000. National Bank of Canada FI bought a new stake in 1Life Healthcare in the fourth quarter valued at approximately $33,000. Aaron Wealth Advisors LLC bought a new stake in shares of 1Life Healthcare during the first quarter worth $212,000. KRS Capital Management LLC bought a new stake in shares of 1Life Healthcare during the fourth quarter worth $44,000. Finally, Sandy Spring Bank increased its position in shares of 1Life Healthcare by 125.4% during the first quarter. Sandy Spring Bank now owns 3,500 shares of the company’s stock worth $39,000 after acquiring an additional 1,947 shares in the last quarter. Institutional investors own 85.50% of the company’s stock.
1Life Healthcare Company Profile
1Life Healthcare, Inc operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs.
- Get a free copy of the StockNews.com research report on 1Life Healthcare (ONEM)
- Three Watchlist Stocks to Capitalize on Sector Rotation
- MarketBeat: Week in Review 7/18 – 7/22
- Falling Copper Prices Weigh On Freeport McMoran’s Earnings, But Long Term Fundamentals Intact
- Snap Stock Falters As Growth Slows To Record Low
- Verizon Shares Drop On Earnings Miss, Lower Guidance
Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.